tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Advertisement

BioMark Diagnostics (BUX) Price & Analysis

Compare
3 Followers

BUX Stock Chart & Stats


BioMark Diagnostics News

BUX FAQ

What was BioMark Diagnostics’s price range in the past 12 months?
BioMark Diagnostics lowest stock price was C$0.18 and its highest was C$0.38 in the past 12 months.
    What is BioMark Diagnostics’s market cap?
    BioMark Diagnostics’s market cap is C$33.63M.
      When is BioMark Diagnostics’s upcoming earnings report date?
      BioMark Diagnostics’s upcoming earnings report date is Jul 29, 2025 which is yesterday.
        How were BioMark Diagnostics’s earnings last quarter?
        Currently, no data Available
        Is BioMark Diagnostics overvalued?
        According to Wall Street analysts BioMark Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BioMark Diagnostics pay dividends?
          BioMark Diagnostics does not currently pay dividends.
          What is BioMark Diagnostics’s EPS estimate?
          BioMark Diagnostics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does BioMark Diagnostics have?
          BioMark Diagnostics has 90,886,230 shares outstanding.
            What happened to BioMark Diagnostics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of BioMark Diagnostics?
            Currently, no hedge funds are holding shares in TSE:BUX

            Company Description

            BioMark Diagnostics

            BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

            BioMark Diagnostics (BUX) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Diagnos
            Medivolve Inc
            Telo Genomics Corp
            StageZero Life Sciences Ltd
            Sona Nanotech Inc

            Ownership Overview

            55.44%44.56%
            55.44% Insiders
            Mutual Funds
            ― Other Institutional Investors
            44.56% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis